To model the effects of PI3K pathway inhibition in aromatase-inhibitor-resistant breast cancer cells, variants of the MCF7 and T47D lines were generated through LTED by over 9 months of culture in low-estrogen conditions (Figure 5a). The gene discussed is PIK3CA; the disease is breast carcinoma.